|
1
|
Yang W, Lu J, Weng J, et al: Prevalence of
diabetes among men and women in China. N Engl J Med. 362:1090–1101.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zimmet P, Alberti KG and Shaw J: Global
and societal implications of the diabetes epidemic. Nature.
414:782–787. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Couzin J: Medicine. Bypassing medicine to
treat diabetes. Science. 320:438–440. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lazar MA: How obesity causes diabetes: not
a tall tale. Science. 307:373–375. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kadowaki T, Hara K, Kubota N, et al: The
role of PPARgamma in high-fat diet-induced obesity and insulin
resistance. J Diabetes Complications. 16:41–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mishima Y, Kuyama A, Tada A, Takahashi K,
Ishioka T and Kibata M: Relationship between serum tumor necrosis
factor-alpha and insulin resistance in obese men with Type 2
diabetes mellitus. Diabetes Res Clin Pract. 52:119–123. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruan H and Lodish HF: Insulin resistance
in adipose tissue: direct and indirect effects of tumor necrosis
factor-alpha. Cytokine Growth Factor Rev. 14:447–455. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Murakami K, Bujo H, Unoki H and Saito Y:
High fat intake induces a population of adipocytes to co-express
TLR2 and TNFalpha in mice with insulin resistance. Biochem Biophys
Res Commun. 354:727–734. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen H, Ren A, Hu S, Mo W, Xin X and Jia
W: The significance of tumor necrosis factor-alpha in newly
diagnosed type 2 diabetic patients by transient intensive insulin
treatment. Diabetes Res Clin Pract. 75:327–332. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li L, Yang G, Shi S, Yang M, Liu H and
Boden G: The adipose triglyceride lipase, adiponectin and visfatin
are downregulated by tumor necrosis factor-alpha (TNF-alpha) in
vivo. Cytokine. 45:12–19. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Garvey WT, Maianu L, Huecksteadt TP,
Birnbaum MJ, Molina JM and Ciaraldi TP: Pretranslational
suppression of a glucose transporter protein causes insulin
resistance in adipocytes from patients with non-insulin-dependent
diabetes mellitus and obesity. J Clin Invest. 87:1072–1081. 1991.
View Article : Google Scholar
|
|
12
|
Zisman A, Peroni OD, Abel ED, et al:
Targeted disruption of the glucose transporter 4 selectively in
muscle causes insulin resistance and glucose intolerance. Nat Med.
6:924–928. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Adams TD, Gress RE, Smith SC, et al:
Long-term mortality after gastric bypass surgery. N Engl J Med.
357:753–761. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Buchwald H and Oien DM:
Metabolic/bariatric surgery Worldwide 2008. Obes Surg.
19:1605–1611. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Laville M and Disse E: Bariatric surgery
for diabetes treatment: why should we go rapidly to surgery.
Diabetes Metab. 35:562–563. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mingrone G and Castagneto-Gissey L:
Mechanisms of early improvement/resolution of type 2 diabetes after
bariatric surgery. Diabetes Metab. 35:518–523. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scheen AJ, De Flines J, De Roover A and
Paquot N: Bariatric surgery in patients with type 2 diabetes:
benefits, risks, indications and perspectives. Diabetes Metab.
35:537–543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Andreelli F, Amouyal C, Magnan C and
Mithieux G: What can bariatric surgery teach us about the
pathophysiology of type 2 diabetes? Diabetes Metab. 35:499–507.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rieusset J, Chambrier C, Bouzakri K, et
al: The expression of the p85alpha subunit of phosphatidylinositol
3-kinase is induced by activation of the peroxisome
proliferator-activated receptor gamma in human adipocytes.
Diabetologia. 44:544–554. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Iwata M, Haruta T, Usui I, et al:
Pioglitazone ameliorates tumor necrosis factor-alpha-induced
insulin resistance by a mechanism independent of adipogenic
activity of peroxisome proliferator--activated receptor-gamma.
Diabetes. 50:1083–1092. 2001. View Article : Google Scholar
|
|
21
|
Antuna-Puente B, Feve B, Fellahi S and
Bastard JP: Adipokines: the missing link between insulin resistance
and obesity. Diabetes Metab. 34:2–11. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hotamisligil GS, Budavari A, Murray D and
Spiegelman BM: Reduced tyrosine kinase activity of the insulin
receptor in obesity-diabetes. Central role of tumor necrosis
factor-alpha. J Clin Invest. 94:1543–1549. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hotamisligil GS, Peraldi P, Budavari A,
Ellis R, White MF and Spiegelman BM: IRS-1-mediated inhibition of
insulin receptor tyrosine kinase activity in TNF-alpha- and
obesity-induced insulin resistance. Science. 271:665–668. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Stephens JM and Pekala PH: Transcriptional
repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes
by tumor necrosis factor-alpha. Regulations is coordinate and
independent of protein synthesis. J Biol Chem. 267:13580–13584.
1992.
|
|
25
|
Fernandez-Veledo S, Hernandez R, Teruel T,
Mas JA, Ros M and Lorenzo M: Ceramide mediates TNF-alpha-induced
insulin resistance on GLUT4 gene expression in brown adipocytes.
Arch Physiol Biochem. 112:13–22. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mingrone G, Rosa G, Di Rocco P, et al:
Skeletal muscle triglycerides lowering is associated with net
improvement of insulin sensitivity, TNF-alpha reduction and GLUT4
expression enhancement. Int J Obes Relat Metab Disord.
26:1165–1172. 2002. View Article : Google Scholar
|
|
27
|
Chung S, Lapoint K, Martinez K, Kennedy A,
Boysen Sandberg M and McIntosh MK: Preadipocytes mediate
lipopolysaccharide-induced inflammation and insulin resistance in
primary cultures of newly differentiated human adipocytes.
Endocrinology. 147:5340–5351. 2006. View Article : Google Scholar
|
|
28
|
Hotamisligil GS, Shargill NS and
Spiegelman BM: Adipose expression of tumor necrosis factor-alpha:
direct role in obesity-linked insulin resistance. Science.
259:87–91. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Carvalho E, Kotani K, Peroni OD and Kahn
BB: Adipose-specific overexpression of GLUT4 reverses insulin
resistance and diabetes in mice lacking GLUT4 selectively in
muscle. Am J Physiol Endocrinol Metab. 289:E551–561. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brozinick JT Jr, McCoid SC, Reynolds TH,
et al: GLUT4 overexpression in db/db mice dose-dependently
ameliorates diabetes but is not a lifelong cure. Diabetes.
50:593–600. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abel ED, Peroni O, Kim JK, et al:
Adipose-selective targeting of the GLUT4 gene impairs insulin
action in muscle and liver. Nature. 409:729–733. 2001. View Article : Google Scholar : PubMed/NCBI
|
